Abstract 17837: The Economic Impact of Favorable Cardiovascular Health in a Large US Employee Population: The Baptist Health South Florida (BHSF) Employee Study
Introduction: A recent American Heart Association (AHA) Presidential Advisory document promoted the adoption of Life’s Simple 7 (LS7) metrics to track success of employee wellness programs optimizing cardiovascular health (CVH). In this study, we aimed to quantify the impact of varying CVH status on healthcare expenditure among employees of Baptist Health South Florida (BHSF), a large nonprofit healthcare organization.
Methods: BHSF employees participating in a health risk assessment in 2014 were assessed for CVH status using the AHA LS7 construct. Participants were categorized according to number of metrics for which ideal levels were met as high (6-7 metrics), moderate (3-5 metrics) and low (0-2 metrics) CVH. Annual healthcare expenditure from health insurance claims data was aggregated and de-identified via an independent third party guided by institutional honest broker. Employees with missing information of interest & women pregnant just prior to or during the HRA were excluded from the study analysis.
Results: The final study population consisted of 8841 participants (43 ± 12.1 years, 75% female) employees, of which 1017 (11.5%) had high, 7649 (76.3%) moderate, and 1075 (12.2%) low CVH status. Overall, a significantly lower health expenditure was noted with high CVH status in the total study cohort and across ethnic subgroups (figure). Annual healthcare expenditures with moderate & high CVH were $4330 (95% CI: 2787 - 4330) and $5895 (95% CI: 4253 - 7538) less compared to those with low CVH. After accounting for demographics, educational status and comorbid conditions, adjusted cost differences were attenuated, however costs for moderate and high CVH remained lower by $1237 (95% CI: 146 - 2328) & $2330 (95% CI: 1037 - 3624), respectively than for low CVH status.
Conclusion: Our findings support the AHA emphasis on the LS7 construct to optimize CVH in employee populations with the objective of attaining favorable outcomes and reducing healthcare costs/ expenditure.
Author Disclosures: C.U. Osondu: None. E.C. Aneni: None. J. Valero-Elizondo: None. J.A. Salami: None. A. Younus: None. M. Rouseff: None. S. Das: None. T. Feldman: None. E. Veledar: None. A.S. Agatston: None. B. Katzen: None. C. Calitz: Employment; Significant; Mr. Calitz is the Director, Health Programs and Evaluation at American Heart Association. E. Sanchez: Employment; Significant; Dr. Sanchez is the Chief Medical Officer for Prevention for the AHA. D.M. Lloyd-Jones: None. K. Nasir: Consultant/Advisory Board; Modest; Dr. Nasir is on the advisory board for Quest Diagnostic and a consultant for Regeneron.
- © 2016 by American Heart Association, Inc.